Amaero to re-domicile to Delaware with US HoldCo securities on ASX

Federal Court Approves Scheme Meetings and Booklet Registration

Amaero Ltd (ASX:3DA) has cleared a major legal hurdle in its plan to re-domicile from Australia to the United States. The Federal Court of Australia has ordered the convening of shareholder and option holder meetings, and approved the dispatch of the Scheme Booklet outlining the terms of the re-domiciliation.

The Scheme Meetings are scheduled for Friday, 5 June 2026, with the Share Scheme Meeting commencing at 10:00am (Sydney time) and the Option Scheme Meeting following shortly after. The Scheme Booklet has also been registered by ASIC and is being sent to all eligible shareholders and option holders.

Re-domiciliation via Delaware US HoldCo to Retain ASX Listing

The transaction involves a newly formed Delaware corporation, Amaero US HoldCo, acquiring 100% of Amaero's issued shares. Shareholders will receive one CHESS Depositary Interest (CDI) in Amaero US HoldCo for every Amaero share held, maintaining their proportional economic interest but now in a US-domiciled entity. Option holders will swap their existing options for equivalent options in Amaero US HoldCo, exercisable into the new CDIs.

This structure allows Amaero to retain its ASX listing through the CDIs, which represent a 1/40th beneficial interest in a single Amaero US HoldCo share. The exchange ratio effectively consolidates Amaero’s capital base on a 40-to-1 basis, but shareholders’ relative ownership remains unchanged. The new CDIs are expected to commence trading on ASX on a deferred settlement basis from 12 June 2026 and transition to normal T+2 settlement on 23 June 2026.

Independent Expert Supports Schemes; Board Recommends Approval

McGrathNicol Transaction Advisory Pty Limited, the independent expert, has concluded that the schemes are in the best interests of Amaero shareholders and option holders, absent any superior proposal. The Amaero Board unanimously recommends voting in favour of the schemes, subject to the expert maintaining its positive opinion.

The Board highlights several strategic benefits of the re-domiciliation, including positioning Amaero in a deeper US capital market, improving access to a broader US investor pool, and simplifying the corporate structure for potential future mergers or acquisitions. Importantly, the move is expected to enhance Amaero’s ability to secure classified contracts with the US Department of War by mitigating foreign ownership concerns.

The schemes also include a proposal to issue 600,000 unlisted options to Tim Johnson under the Employee Incentive Plan, subject to shareholder approval at an extraordinary general meeting to be held immediately after the Option Scheme Meeting.

Financial and Operational Context Underpinning the Transaction

Amaero’s financials show rapid revenue growth, with a 367% increase to A$7.76 million in H1 FY2026 driven by powder sales and manufacturing services, although losses continue amid ongoing investment. The company has secured significant contracts, including a A$7.8 million Master Purchasing Agreement for titanium powders, underpinning plans to double production in FY2027, reflecting strong market demand and commercial traction Master Purchasing Agreement.

Strategic partnerships with industry leaders such as Velo3D and Titomic, along with a letter of support from the US Department of the Navy validating its PM-HIP manufacturing technology, underscore Amaero’s growing footprint in the defense and advanced manufacturing sectors. The company’s Tennessee facility has undergone major infrastructure upgrades, positioning it for scale.

Legal and Tax Implications of the US Re-domiciliation

The re-domiciliation will shift Amaero’s legal governance from Australian to Delaware corporate law, with associated changes in shareholder rights, corporate governance, and potential exposure to a more litigious US legal environment. Shareholders will hold CDIs rather than direct shares, with voting rights exercised via CHESS Depositary Nominees, an arrangement that differs from current direct shareholding.

Tax implications are complex and depend on individual circumstances. The company provides detailed guidance on Australian and US tax consequences, including potential capital gains tax roll-over relief and implications of holding securities in a US entity. Shareholders are urged to seek independent tax advice.

The transaction is conditional on multiple regulatory approvals, including ASIC, ASX, and court approvals, with a second court hearing scheduled for 10 June 2026 to confirm final sanction. Shareholders and option holders who do not vote or vote against the schemes may still be bound if the requisite majorities approve the transaction.

What to Watch Next

Investors should monitor the upcoming Scheme Meetings on 5 June and the court hearing on 10 June for final approval outcomes. The market will also be watching the trading debut of Amaero US HoldCo CDIs on ASX and any developments regarding the proposed US IPO targeted for late 2026 or early 2027. The success of the re-domiciliation in unlocking US capital and government contracts remains to be seen, as does shareholder reception to the new legal and tax regime.

Potential risks include uncertainties around valuation of the new CDIs post-implementation, exposure to US litigation, and the complex tax landscape. The company’s ability to capitalize on strategic partnerships and government support will be critical to translating the structural benefits into shareholder value.